Partners III Lp Aberdare serves as Executive at Conatus Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Partners III Lp Aberdare has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 19, 2014 involved transacting 36,634 shares valued at $0.
Partners III Lp Aberdare currently holds 36,634 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners III Lp Aberdare has been a net neutral trader of CNAT stock. They have purchased $0 and sold $0 worth of shares.
Partners III Lp Aberdare's most recent insider trade was on Feb 19, 2014, when they sold 36,634 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 19, 2014 | CNAT | $0 | Other | 30,216 | $N/A | Discretionary |
| Feb 19, 2014 | CNAT | $0 | Other | 1,283,589 | $N/A | Discretionary |